Early experience of dolutegravir pharmacokinetics in pregnancy: High maternal levels and significant foetal exposure with twice-daily dosing: High maternal levels and significant foetal exposure with twice-daily dosing

Joe Lewis; Eimear Railton; Andrew Riordan; Saye Khoo; Mas Chaponda

doi:10.1097/qad.0000000000001055

Early experience of dolutegravir pharmacokinetics in pregnancy: High maternal levels and significant foetal exposure with twice-daily dosing: High maternal levels and significant foetal exposure with twice-daily dosing

Joe Lewis
, Eimear Railton
, Andrew Riordan
, Saye Khoo
, Mas Chaponda

Liverpool University Hospitals NHS Foundation Trust
Wellcome Trust
Alder Hey Children's NHS Foundation Trust
University of Liverpool

Research output: Contribution to journal › Letter › peer-review

15 Citations (Scopus)

Original language	English
Pages (from-to)	1313-1315
Number of pages	3
Journal	AIDS
Volume	30
Issue number	8
DOIs	https://doi.org/10.1097/qad.0000000000001055
Publication status	Published - 15 May 2016
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1097/qad.0000000000001055

Cite this

@article{de301ec7bc054e7f9079f885c4684f01,

title = "Early experience of dolutegravir pharmacokinetics in pregnancy: High maternal levels and significant foetal exposure with twice-daily dosing: High maternal levels and significant foetal exposure with twice-daily dosing",

author = "Joe Lewis and Eimear Railton and Andrew Riordan and Saye Khoo and Mas Chaponda",

year = "2016",

month = may,

day = "15",

doi = "10.1097/qad.0000000000001055",

language = "English",

volume = "30",

pages = "1313--1315",

journal = "AIDS",

issn = "0269-9370",

publisher = "Lippincott Williams and Wilkins",

number = "8",

}

Early experience of dolutegravir pharmacokinetics in pregnancy: High maternal levels and significant foetal exposure with twice-daily dosing: High maternal levels and significant foetal exposure with twice-daily dosing. / Lewis, Joe; Railton, Eimear; Riordan, Andrew et al.
In: AIDS, Vol. 30, No. 8, 15.05.2016, p. 1313-1315.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - Early experience of dolutegravir pharmacokinetics in pregnancy: High maternal levels and significant foetal exposure with twice-daily dosing: High maternal levels and significant foetal exposure with twice-daily dosing

AU - Lewis, Joe

AU - Railton, Eimear

AU - Riordan, Andrew

AU - Khoo, Saye

AU - Chaponda, Mas

PY - 2016/5/15

Y1 - 2016/5/15

U2 - 10.1097/qad.0000000000001055

DO - 10.1097/qad.0000000000001055

M3 - Letter

SN - 0269-9370

VL - 30

SP - 1313

EP - 1315

JO - AIDS

JF - AIDS

IS - 8

ER -